Successful use of rituximab in a patient with refractory thrombotic thrombocytopaenic purpura complicated by polymyositis

Scand J Rheumatol. 2017 Mar;46(2):163-165. doi: 10.1080/03009742.2016.1181204. Epub 2016 Jun 16.

Authors

H Takada¹, T Hosoya¹, N Kimura¹, K Kawahata¹, H Kohsaka¹

Affiliation

¹ a Department of Rheumatology, Graduate School of Medical and Dental Sciences , Tokyo Medical and Dental University (TMDU) , Japan.

PMID: 27309121
DOI: 10.1080/03009742.2016.1181204

No abstract available

Publication types

Case Reports
Letter

MeSH terms

ADAMTS13 Protein / immunology*
Amino Acyl-tRNA Synthetases / immunology*
Drug Resistance
Female
Glucocorticoids / administration & dosage
Glucocorticoids / adverse effects
Humans
Immunologic Factors / administration & dosage
Middle Aged
Polymyositis* / blood
Polymyositis* / diagnosis
Polymyositis* / etiology
Polymyositis* / therapy
Purpura, Thrombotic Thrombocytopenic* / blood
Purpura, Thrombotic Thrombocytopenic* / complications
Purpura, Thrombotic Thrombocytopenic* / diagnosis
Purpura, Thrombotic Thrombocytopenic* / physiopathology
Rituximab / administration & dosage*
Treatment Outcome

Substances

Glucocorticoids
Immunologic Factors
Rituximab
ADAMTS13 Protein
Amino Acyl-tRNA Synthetases